Losenkov, I.
23  results:
Search for persons X
?
1

P.346 Influence of lithium pyruvate on expression of AKT/mT..:

Epimakhova, E. ; Plotnikov, E. ; Boiko, A..
European Neuropsychopharmacology.  40 (2020)  - p. S200-S201 , 2020
 
?
2

Association of polymorphic variants of genes of kinase sign..:

Vyalova, N. ; Losenkov, I. ; Simutkin, G..
European Neuropsychopharmacology.  29 (2019)  - p. S331-S332 , 2019
 
?
3

Genes of neurotrophic factors and responsiveness to antidep..:

Levchuk, L. ; Losenkov, I. ; Pozhidaev, I....
European Neuropsychopharmacology.  29 (2019)  - p. S341-S342 , 2019
 
?
 
?
 
?
6

P.322 Assessment of association of polymorphic variants of ..:

Mikhalitskaya, E. ; Vyalova, N. ; Losenkov, I....
European Neuropsychopharmacology.  29 (2019)  - p. S230-S231 , 2019
 
?
7

P.505 The potential role of BDNF and prolactin genotypes on..:

Vyalova, N. ; Ochi, T. ; Losenkov, I....
European Neuropsychopharmacology.  29 (2019)  - p. S355-S356 , 2019
 
?
8

DRD2 gene polymorphisms association with severity of depres..:

Losenkov, I. ; Pozhidaev, I.V. ; Osmanova, D.Z..
European Neuropsychopharmacology.  26 (2016)  - p. S173-S174 , 2016
 
?
11

P.0579 Pharmacogenetic study to elucidate putative dopamine..:

Ochi, T. ; Vyalova, N.M. ; Losenkov, I.S....
European Neuropsychopharmacology.  53 (2021)  - p. S424-S425 , 2021
 
?
 
?
 
?
15

Gene polymorphisms of enzymes biotransformation of xenobiot..:

Levchuk, L. ; Losenkov, I.S. ; Lebedeva, E.V....
European Neuropsychopharmacology.  27 (2017)  - p. S800-S801 , 2017
 
1-15